Patent ID: 9180319
Filing Date: 2015-11-10
Classification: A61C,A61K,A61N,A61Q

Abstract:
1. A substrate mixture for the treatment of gum disease, wherein the substrate mixture is comprised of: a) a first substrate; and b) a second substrate, wherein the first substrate is comprised of: a) between 40% and 80% sterile water b) 1.1% sodium chloride; c) 1% benzoic acid; d) 9% lysine; e) 9% proline; f) 9% essential amino acids, wherein the essential amino acids include equal parts isoleucine, leucine, methionine, phenylalanine, threonine, tryptophan, valine and histadine; g) 2% non-essential amino acids, wherein the non-essential amino acids include equal parts alanine, arginine, glutamate, glycine and serine; h) 2% phosphates, wherein the phosphates include equal parts adenosine diphospate (ADP), adenosine triphosphate (ATP), and acetylcholine; and i) 6.9% free bases, wherein the free bases include equal parts adenosine, uridine, guanosine, and cytidine.